Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India [Phase 3]

View source ↗

Summary

Phase 3 trial assessing immunogenicity and safety of a meningococcal ACWY conjugate vaccine in healthy individuals aged 2 to 75 in India; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Meningitis

Drugs mentioned

• Meningococcal ACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Novartis | Conditions: Bacterial Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2014-12-31